Galderma delivers net sales of 4.765 B USD in the first nine months, up 25.1% at constant currency year-on-year, and raises full-year net sales guidance Press release
Galderma signs agreement to acquire ZO Skin Health, strengthening its physician-dispensed skincare offering Press release
Galderma reports record first half 2026 net sales of 3.134 billion USD and 24.6% year-on-year growth at constant currency, raises net sales guidance for the full year Press release
Galderma provides progress update regarding RelabotulinumtoxinA regulatory submission in the United States Press release
Galderma reports strong start to the year, delivering first quarter 2026 net sales of 1.473 billion USD, growing 25.5% at constant currency Press release
Galderma buys back shares worth CHF 232 million in the context of accelerated bookbuild offering Press release
Galderma delivers record 2025 results with net sales of 5.207 billion USD, up 17.7% at constant currency, and Core EBITDA of 1.211 billion USD, growing 18.9% at constant currency Press release
